top of page
International-Medicl-Device-Group,-Inc.-logo

presents

presents

ABSTRACT

Empowering Self-Cannulation:
A Patent-Pending External Vascular Stabilization Device to
Facilitate Cannulation for Transition to Home Hemodialysis

Despite the well-established advantages of home hemodialysis (HHD)—including greater treatment flexibility, improved quality of life, better fluid and blood pressure control, reduced post-treatment fatigue, and potential survival benefits—many patients remain limited to in-center dialysis due to barriers in self-cannulation. Challenges such as needle instability, fear of pain, infiltration risks, and the frustration of inconsistent first-try success often deter patients from pursuing or continuing HHD. 

International Medical Devices Group Inc. presents a novel, patent pending, external vascular stabilization device specifically engineered to overcome these hurdles and enable safer, more reliable self-cannulation of arteriovenous fistulas. This non-invasive, user-friendly tool provides fistula visualization, secure positioning, and immobilization during needle insertion, minimizing movement, enhancing precision, and reducing complications such as hematomas or infiltrations. Designed with configurable ergonomic features for diverse arm anatomies and intuitive single-handed operation, the device empowers patients to cannulate independently with lower risk of adverse incidents—whether in clinical settings or at home. Additionally, nephrology staff will find this device beneficial in clinical settings.

By addressing a key technical barrier to self-cannulation, specifically rolling vessels, this innovation has the potential to significantly increase the number of patients successfully transitioning to and sustaining HHD. Preliminary prototyping and user insights indicate improved cannulation accuracy, faster needle insertion times (usually less than thirty seconds), heightened patient confidence, and decreased reliance on assistance, paving the way for broader adoption of home-based therapies.

This debut presentation at the 2026 Vascular Access for Hemodialysis Symposium will highlight the device’s design, key features, and clinical rationale with opportunities for interactive demonstrations. By facilitating greater independence in vascular access management, this tool aligns with evolving priorities in dialysis care to promote patient-centered, home-based hemodialysis and improve long-term outcomes.

bottom of page